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I. INTRODUCTION 
The present “Report on the Development, Validation and Legal Acceptance of Alternative 
Methods to Animal Experiments in the Field of Cosmetics” is the sixth report presented by 
the Commission. It reflects the state of play on the number and type of experiments on 
animals relating to cosmetic products in 2004, the current status of alternative replacement 
methods as well as the acceptance and recognition of alternative methods at the international 
level. The report is produced in order to comply with Art. 9 of the Council Directive 
76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating 
to cosmetic products (Cosmetics Directive), as amended by the European Parliament and 
Council Directive 2003/15/EC of 27 February 2003. It is the second report on the basis of the 
7th Amendment to the Cosmetics Directive and after the inclusion of the Protocol on the 
Welfare of Animals in the Treaty of Amsterdam in 1999. 
II. NUMBER AND TYPE OF EXPERIMENTS RELATING TO COSMETIC PRODUCTS CARRIED OUT 
ON ANIMALS 
1. Legal Background 
According to Art. 9 (a) of the Cosmetics Directive, every year the Commission shall present a 
report to the European Parliament and the Council on progress made in the development, 
validation and legal acceptance of alternative methods. The report shall contain precise data 
on the number and type of experiments relating to cosmetic products carried out on 
animals. The Member States shall be obliged to collect that information in addition to 
collecting statistics as laid down by Council Directive 86/609/EEC of 24 November 1986 on 
the approximation of laws, regulations and administrative provisions of the Member States 
regarding the protection of animals used for experimental and other scientific purposes 
(Laboratory Animals Directive). The Laboratory Animals Directive includes reporting 
requirements at regular intervals not exceeding three years on the number and kinds of 
animals used in experiments. 
The information to be provided in accordance with the Cosmetics Directive should enable the 
European Commission and the Member States to get a complete idea of the situation in the 
field of animal testing in relation to cosmetic products. This information will be useful to 
apply the provisions of the Cosmetics Directive on this matter.  
The testing ban on finished cosmetic products applies since 11 September 2004, whereas the 
testing ban on ingredients or combination of ingredients will apply step by step as soon as 
alternative methods are validated and adopted, but with a maximum cut-off date of 6 years 
after entry into force of the Directive, i.e., 11 March 2009, irrespective of the availability of 
alternative non-animal tests. The marketing ban will apply step by step as soon as alternative 
methods are validated and adopted in EU legislation with due regard to the OECD validation 
process. This marketing ban will be introduced at the latest 6 years after entry into force of the 
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Directive, i.e., 11 March 2009, for all human health effects with the exception of repeated-
dose toxicity, reproductive toxicity and toxicokinetics. For these specific health effects, a 
deadline of 10 years after entry into force of the Directive is foreseen, i.e., 11 March 2013, 
irrespective of the availability of alternative non-animal tests.  
2. Animal Testing Data1 
a) For the present report, 23 Member States2 conveyed information on animal tests carried out 
for the safety of cosmetic products in 2004. EL and UK did not transmit any information for 
this report pursuant to Art. 9 (a) of the Cosmetics Directive. Both Member States have 
repeatedly informed the European Commission in the past that they are not carrying out 
animal tests for the development and safety assessment of cosmetic products. 
According to the information submitted, cosmetic ingredients have been tested on animals in 
the territories of FR, DK and ES only. However, as in the last report, these Member States 
have not indicated the number of animal tests performed but instead the number of animals 
used. Also, these figures refer to “main uses” of substances in cosmetics or toiletry articles.  
In total, about 9000 animals were used in tests carried out for the safety of cosmetic products 
(Table 1). The other 20 Member States reported that they did not perform such animal tests in 
their territory in 2004. 
Number of animals used in Member States (2004) – Table 1 
 NUMBER OF ANIMALS USED 
ANIMALS USED 
France 5496 Mice, rats, guinea pigs, rabbits 
Denmark 12 Rats 
Spain 3480 Mice, rats, guinea pigs, rabbits 
Compared to the last report, the total number of animals used for testing the safety of 
cosmetics increased significantly (2003: 1618). At the same time, the market for cosmetics 
has continued to grow by 1 % compared to 2004. Sales for the 15 “old” Member States, 
Switzerland and Norway reached 60 billion Euro (retail sales prices) in 20053.  
There are several reasons for this increase in the number of animals used in the area of 
cosmetics. First, Spain did not transmit animal testing data in 2003, but did so for 2004. The 
increase of animals used in tests in France from about 1600 in 2003 to about 5500 in 2004 is 
caused, according to the French authorities, mainly by three additional test protocols carried 
out by two laboratories, two of which have been carried out for a French client and the other 
one for a client in another EU Member State.  
                                                 
1 See reservations on the accuracy of data in paragraph 3 “evaluation of submitted data”  
2 Bulgaria and Romania were not involved in the reporting system 
3 COLIPA, Annual Market 2005, June 2006, page 5 
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However, the reported number of animals mainly used for cosmetics or toiletries is still 
relatively small compared to the total number of animals used for experimental and other 
scientific purposes. The total number of animals used in the “old” fifteen EU Member States 
in 2002 was 10.7 Million according to the “Fourth Report on the Statistics on the Number of 
Animals used for Experimental and other Scientific Purposes in the Member States of the 
European Union (2002)4”. 
b) For the first time, the Commission received information on the type of animal experiments 
performed in Member States. FR and ES submitted testing data in relation to the various 
toxicological endpoints (Table 2). For some types of animal tests, however, it remains unclear 
for what kind of human health effects they have been tested (“others”). 
Number of Animals Used in Relation to Toxicological Endpoints (2004) – Table 2 
TYPES OF TESTS / COUNTRIES FRANCE SPAIN DENMARK 
Tests of non lethal toxicity methods 629 No data No information 
Skin irritation 283 No data No information 
Skin sensitisation 875 1282 No information 
Eye irritation 115 No data No information 
Subchronic and chronic toxicity 1279 1242 No information 
Carcinogenicity 418 No data No information 
Development Toxicity 231 No data No information 
Mutagenicity 206 No data No information 
Reproductive Toxicity 310 No data No information 
Others 998 801 No information 
3. Evaluation of submitted data 
                                                 
4 COM (2005) 7 of 20.01.2005 
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a) Reporting of animal testing data under the Cosmetics Directive has slightly been improved 
compared to the last report, although a number of questions and shortcomings remain. This 
again highlights the Commissions’ continued concerns about the accuracy of the figures being 
reported. 
After publication of the last annual report, the Commission has undertaken a number of 
efforts to clarify the situation and to assist Member States in collating accurate figures in 
relation to animal testing data. The Commission contacted Member States and other relevant 
stakeholders to clarify the collation of animal testing data, in particular with a view to animal 
tests carried out for multiple uses. 
Several discussions with industry, animal welfare organisations and other stakeholders 
showed that:  
• chemicals are rarely tested on animals solely for their use as ingredients in 
cosmetics, 
• the majority of animal tests are carried out for multiple uses by manufacturers of 
chemical substances (industry assumes that approximately 80-90% of cosmetic 
ingredients are tested for multiple uses), 
The Commission also provided Member States with guidance on the interpretation of the 
reporting requirements laid down in Art. 9 (a) of the Cosmetics Directive and discussed ways 
and means of gathering complete and accurate animal testing data in the field of cosmetics.  
b) The information the Commission received from Member States for the present report 
demonstrates how difficult it is to generate accurate figures on animal testing in the field of 
cosmetics. Data on animal tests relating to cosmetic products are collated and generated 
differently throughout the European Union. There is no uniform practice to collate animal 
testing data in an accurate manner. In particular, the collation of relevant multiple use tests 
remains a significant problem.  
Member States are confronted with two different reporting systems relating to the use of 
laboratory animals, namely the Laboratory Animals Directive 86/609/EEC and the Cosmetics 
Directive 76/768/EEC. The Cosmetics Directive has established much more ambitious 
reporting requirements than the Laboratory Animals Directive and Member States still have 
difficulties to adapt to this situation.  
It can be assumed that the current situation does not fully provide for the collection of 
accurate data required under the Cosmetics Directive due to practices at national level. Some 
Member States 
• collate data on the basis of an authorisation-/notification-procedure for animal 
tests, but these procedures do not ensure concrete information on the number and 
type of animal tests carried out in relation to cosmetic products;  
• collate animal testing data according to “main uses” on the basis of Art. 13 of the 
Laboratory Animals Directive 86/609/EEC; 
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• request animal testing data from cosmetic companies although there is no 
downstream information on animal testing data from the chemicals manufacturer 
or other suppliers to the cosmetics manufacturer; 
• claim that, according to their national legislation, animal tests are prohibited for 
the development of cosmetic products; this information, however, does not clarify 
how Member States break down figures for multiple use tests, which can include 
cosmetics use. 
c) It is up to each Member State to establish an internal structure enabling it to collate and 
transmit to the European Commission precise data on the number and type of experiments 
relating to cosmetic products carried out on animals. Member States have the choice to 
establish their own mechanisms to collate animal testing data. However, these mechanisms 
shall ensure that all relevant test data are collated and transmitted to the European 
Commission for publication in the annual report. The European Commission is currently 
working on guidelines in order to facilitate accurate generation and collation of animal testing 
data relating to cosmetic products.  
III. Progress in the Development, Validation and Legal Acceptance of Alternative 
Methods 
1. Legally Accepted Replacement Methods 
There are currently four alternative in vitro methods in relation to two toxicological endpoints 
(skin corrosion and acute phototoxicity) listed in Annex V of Directive 67/548/EEC. These 
alternative test methods are currently the only legally accepted tests at Community level 
aiming at fully replacing animal tests for toxicological endpoints in the area of chemicals and 
cosmetics. 
The in vitro tests for skin corrosivity and the in vitro 3 T 3 NRU phototoxicity test were 
introduced into Part B (B. 40 and 41) of Annex V to Directive 67/548/EEC by Directive 
2000/33/EC of 25 April 2000 and are to be applied in the framework of the testing and 
marketing bans under the Cosmetics Directive since 11 September 2004 (Art. 3 of Directive 
2003/15/EC). 
2. Progress in Development and Validation of Alternative Approaches 
a) On 1 October 2004, the Commission established the timetables for the phasing-out of 
animal testing according to Art. 4 a §2 of the Cosmetics Directive. In order to estimate the 
time necessary to achieve full replacement of animal testing in the field of cosmetics, the 
Commission set up an Ad Hoc Group with representatives from industry, academia, animal 
welfare groups and governmental bodies that agreed on a “Report Prepared in the Context of 
the 7th Amendment of the Cosmetics Directive for Establishing the Timetable for Phasing Out 
Animal Testing”5. The Ad Hoc Working Group was re-launched in 2005 to monitor the 
progress on development, validation and legal acceptance of alternative methods to animal 
tests for cosmetic products. As a contribution to this process, the European Centre for 
Validation of Alternative Methods (ECVAM) of the EC’s Joint Research Centre (JRC) 
                                                 
5 ATLA, Vol.33, Supplement 1, July 2005 
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prepared a “Cosmetics Technical Report” which was submitted to Member States and all 
relevant stakeholders for consultation6.  
The “Cosmetics Technical Report” assesses the possibility to fully replace animal tests before 
the cut-off dates provided by Art. 4 a of the Cosmetics Directive in a differentiated manner:  
• The concerted activities seem promising for meeting the 2009 deadline. For skin 
corrosion, acute phototoxicity and skin penetration, accepted replacement assays 
already exist, whereas for mutagenicity accepted partial replacement assays exist. 
Results from a validation study on acute skin irritation look promising for meeting 
the deadline. Significant progress is also being made in the areas of eye irritation 
although additional work is still needed in order to fully replace the animal test. 
For acute toxicity, the results of a completed validation study indicate the 
possibility to identify non-toxic substances without the use of animals. 
Furthermore, as a result of the FP6 integrated project A-Cute-Tox (2005-2010) the 
proportion of substances, for which acute toxicity can be established, might be 
expanded in the near future. 
• For the 2013 deadline, the situation is much more critical. It is highly unlikely that 
it will be possible to predict chronic toxicity with any test strategy or battery of 
non-animal tests. For reproductive toxicity some opportunities from the 
ReProTect project (2004-2009) might emerge. Cancer bioassays are very unlikely 
to be requested for cosmetic ingredients, since chemicals identified as positive in 
mutagenicity/genotoxicity assays are usually abandonned. However, in case the 
carcinogenic potential needs to be evaluated, cell transformation assays, which are 
currently under validation, might be used. Promising alternative methods exist for 
skin and respiratory sensitisation (currently tests under validation might allow the 
identification of large parts of non-sensitizers), and the integrated project Sens-it-
iv seeks for new methods (2005-2010). 
b) During the reporting period, increased efforts and numerous activities have been launched 
at EU-level to promote alternative approaches to animal testing. Most of them are of a more 
general nature but cover also the cosmetics sector. 
• Developing robust and effective novel, alternative methods is a priority under the 
Framework Research Programmes of the European Union since more than twenty 
years. Between 1999 and 2002, the EU supported 43 research projects with 65 
million Euro, several of which are still ongoing. In the current 6th Framework 
Programme on Research and Development, 20 projects were awarded with 80 
million Euro by the Health Programme, and two projects on Intelligent Testing 
Strategies for chemicals and (Q)SARs, for about 12 Million Euro were awarded 
by the Global Change and Ecosystems Programme. Research activities will 
continue under 7th Framework Research Programme (2007-2013) through a 
coordinated activity on alternative methods and strategies for safety testing on 
pharmaceuticals and cosmetics (in the Health Programme) as well as industrial 
chemicals (in the Environment Programme). 
                                                 
6 The “Cosmetics Technical Report” as well as stakeholder- and additional ECVAM-comments are 
available on http://ec.europa.eu/enterprise/cosmetics/html/cosm_animal_test.htm.  
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• On 7 June 2006, the Commission adopted a Recommendation Establishing 
Guidelines on the Use of Claims referring to the Absence of Tests on Animals 
pursuant to Council Directive 76/768/EEC7. Further activities in relation to 
alternative approaches to animal testing have been launched at EU level, such as 
the European Partnership for Alternative Approaches to Animal Testing (EPAA)8, 
the Community Action Plan on the Protection and Welfare of Animals9, the 
revision of the Laboratory Animals Directive 86/609/EEC10 and the revision of 
SCCNFP’s Notes of Guidance for the Testing of Cosmetic Ingredients and their 
Safety Evaluation.  
• Private initiatives, such as those by the European Consensus-Platform for 
Alternatives (ECOPA)11 and the Steering Committee on Alternatives to Animal 
Testing of the European Cosmetic Toiletry and Perfumery Association (SCAAT), 
also play a crucial role in promoting alternative test methods. Since 1992, 
SCAAT’s main mission is the coordination of the Cosmetics Industry’s efforts in 
the development and acceptance of alternatives to animals in cosmetic safety 
evaluation. It's work is based on collaboration – not only between member 
companies – but also with other groups who have a legitimate interest in the 
outcome of the research (academia, industrial trade associations, national research 
and regulatory bodies). Research comprises the understanding of biological 
mechanisms, method/strategies development, method optimisation, as well as 
prevalidation and validation in collaboration with ECVAM. The Colipa / SCAAT 
research programme focuses on the main areas of needs and expertise: skin and 
eye irritation, skin allergy, genotoxicity and risk assessment methodology12.  
 
                                                 
7 OJ L 158 of 10.06.2006, page 18 
8 For further information see http://www.ec.europa.eu/enterprise/epaa/index_en.htm 
9 COM (2006) 13 final, 23.1.2006 
10 For further information see http://ec.europa.eu/environment/chemicals/lab_animals/revision_en.htm 
11 For further information see http://www.ecopa.eu/ 
12 For further information in this context see the “COLIPA Contribution” to the “Cosmetics Technical 
Report” of ECVAM http://ec.europa.eu/enterprise/cosmetics/html/cosm_animal_test.htm 
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Development, Validation and Acceptance of Alternative Methods in relation to 
Toxicological Endpoints applicable in the area of Cosmetics (State of Play) – Table 3 13 
 
 
 Validated and legally accepted methods aiming at fully replacing animal tests 
for the relevant toxicological endpoints14 
 
 Validated methods aiming at fully replacing animal tests for the relevant 
toxicological endpoints 
 
 Alternative methods under development and/or under validation by ECVAM. 
 
IV. ACCEPTANCE AND RECOGNITION OF ALTERNATIVE METHODS AT INTERNATIONAL 
LEVEL 
1. Multilateral Level 
OECD might play the most prominent role in promoting and accepting alternative methods at 
international level. OECD Test Guidelines (TG) are broadly accepted by the international 
scientific community and by appropriate regulatory authorities of OECD Member countries 
                                                 
13 1st figure in brackets represents the cut-off date for the testing ban in relation to the respective 
toxicological end point (Art. 4 a para 1d of the Cosmetics Directive) ; 2nd figure represents the cut-off 
date for the marketing bans in relation to the respective toxicological end point (Art. 4 a para 1 a and b 
of the Cosmetics Directive) 
14 Validated and legally accepted alternative methods are also available in relation to other toxicological 
endpoints, such as genotoxicity and mutagenicity, but these methods are not designed to fully replace 
animal testing for the relevant endpoints. 
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and a number of Non-Member countries. The EC-DG JRC’s ECVAM is closely working with 
the OECD in the validation, acceptance and promotion of alternative methods. 
In 2004, OECD adopted for the first time alternative methods aiming at replacing animal tests 
(skin absorption, TG 428; skin corrosion, TG 430 and 431; phototoxicity, TG 432). 
2. Bilateral Level 
The EU takes also a leading role in the international regulatory dialogues with authorities in 
USA and Japan in order to facilitate the compatibility of cosmetics regulations and to avoid 
trade conflicts. A key element of the EU-US cooperation is the implementation of the 
Guidelines for Regulatory Cooperation and Transparency agreed in June 2002 under the 
Transatlantic Economic Partnership (1998) in the framework of the New Transatlantic 
Agenda (1995). 
In the 2005 roadmap for US-EU Regulatory Cooperation the EU and the US agreed that “the 
cooperation on the development of alternative methods needs further strengthening through 
bilateral contacts with the aim of mutual acceptance of alternative methods.” A recent 
example for this cooperation is the active participation of US regulators at the EPAA 
Conference on Alternative Approaches to Animal Testing on 7 November 2005 in Brussels, 
organized by Vice President of the European Commission Günter Verheugen and 
Commissioner Janez Potočnik.  
In 2003, the Commission and the US Food and Drug Administration (FDA) agreed on 
cooperation in cosmetics regulation for the validation of alternative test methods. In this 
cooperation agreement it was agreed to aim at 
• co-operation and early exchange of information on the validation of test methods 
so as to facilitate mutual recognition, acceptance, and implementation of 
scientifically validated testing methods and 
• joint efforts to facilitate the OECD process in providing harmonized protocols to 
the scientific community and promoting international adoption of validated 
alternative methods. 
In the scientific field, since 1995, ECVAM co-operates with the US Interagency Co-
ordinating Committee on the Validation of Alternative Methods (ICCVAM) with a view to an 
early exchange of information on the validation of test methods so as to facilitate mutual 
recognition, acceptance, and implementation of scientifically validated testing methods; and 
at joint efforts to facilitate the OECD process in providing harmonised protocols to the 
scientific community and promoting international adoption of validated alternative methods. 
This cooperation was extended to the Japanese Centre for the Validation of Alternative 
Methods (“JACVAM”) which was founded in December 2005. Already now, ICCVAM, 
JACVAM and ECVAM are discussing the creation of an International Council of Validation 
Bodies, in order to harmonize procedures and collaborate strategically with OECD. 
V. CONCLUSIONS 
According to the information from Member States received for the present report, it can be 
doubted whether all Member States have established mechanisms which provide for accurate 
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animal testing data and effective monitoring of the application of the testing and marketing 
bans. 
The European Commission is currently working on guidelines in order to facilitate accurate 
generation and collation of animal testing data relating to cosmetic products for the next 
annual report.  
There are currently four alternative in vitro methods in relation to two toxicological endpoints 
(skin corrosion and acute phototoxicity) listed in Annex V of Directive 67/548/EEC. These 
alternative test methods are currently the only legally accepted tests at Community level 
aiming at fully replacing animal tests for toxicological endpoints in the area of chemicals and 
cosmetic products. However, concerted activities on the development and validation of 
alternative approaches seem promising for meeting the 2009 deadline provided by Art. 4 a of 
the Cosmetics Directive. For the 2013 deadline, the situation is much more critical. The 
replacement of animal test methods by alternative methods in relation to complex 
toxicological endpoints remains scientifically difficult, despite the additional efforts launched 
at different levels. 
